A Potential Drug Target: FAM86KP (G100287013)

Target Name: FAM86KP

NCBI ID: G100287013

FAM86KP

Other Name(s): Family with sequence similarity 86 member K, pseudogene | family with sequence similarity 86 member K, pseudogene

A Potential Drug Target: FAM86KP

FAM86KP is a protein that is expressed in various tissues and cell types in the human body. Its function and specificity have not yet been fully determined, but recent studies have suggested that it may be a potential drug target or biomarker. In this article, we will explore the potential drug target of FAM86KP and its potential as a biomarker for various diseases.

FAM86KP: Structure and Expression

The FAM86KP protein is a member of the FAM86KP family, which is characterized by the presence of a single transmembrane domain and a unique N-terminal region that contains a leucine-rich repeat (LRR) and a conserved glycine-rich repeats (GGR) sequence. FAM86KP is expressed in various tissues and cell types, including the brain, heart, skeletal muscles, and tissues.

Function and Potential Therapeutic Applications

FAM86KP has been shown to play a role in various physiological processes in the body, including cell signaling, neurotransmission, and muscle function. Its expression has also been linked to various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

As a potential drug target, FAM86KP may be targeted by small molecules or antibodies that can modulate its activity and activity levels. This could lead to the development of new treatments for diseases that are currently untreated or underserved.

FAM86KP as a Biomarker

FAM86KP has also been shown to be expressed in various biomarkers for disease, including cancer, neurodegenerative diseases, and cardiovascular diseases. Its expression has been used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

In cancer, FAM86KP has been shown to be expressed in various cell types and has been linked to the development and progression of cancer. Its expression has also been used as a biomarker for monitoring the effectiveness of anti-cancer drugs.

In neurodegenerative diseases, FAM86KP has been shown to be expressed in various brain regions and has been linked to the development and progression of neurodegenerative diseases. Its expression has also been used as a biomarker for monitoring the effectiveness of neurodegenerative disease treatments.

In cardiovascular diseases, FAM86KP has been shown to be expressed in various heart and blood vessel tissues and has been linked to the development and progression of cardiovascular diseases. Its expression has also been used as a biomarker for monitoring the effectiveness of cardiovascular disease treatments.

Conclusion

FAM86KP is a protein that has been shown to play a role in various physiological processes in the body and has been linked to various diseases. Its expression has also been used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. As a potential drug target, FAM86KP may be targeted by small molecules or antibodies that can modulate its activity and activity levels. With further research, FAM86KP may lead to the development of new treatments for diseases that are currently untreated or underserved.

Protein Name: Family With Sequence Similarity 86 Member K, Pseudogene

The "FAM86KP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM86KP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets